Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Detalles Bibliográficos
Autores principales: Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520022/
https://www.ncbi.nlm.nih.gov/pubmed/33739363
http://dx.doi.org/10.1093/asj/sjab111
_version_ 1784584578376138752
author Ascher, Benjamin
Rzany, Berthold
Kestemont, Philippe
Hilton, Said
Heckmann, Marc
Bodokh, Isaac
Noah, Ernst Magnus
Boineau, Dominique
Kerscher, Martina
Volteau, Magali
Le Berre, Philippe
Picaut, Philippe
author_facet Ascher, Benjamin
Rzany, Berthold
Kestemont, Philippe
Hilton, Said
Heckmann, Marc
Bodokh, Isaac
Noah, Ernst Magnus
Boineau, Dominique
Kerscher, Martina
Volteau, Magali
Le Berre, Philippe
Picaut, Philippe
author_sort Ascher, Benjamin
collection PubMed
description
format Online
Article
Text
id pubmed-8520022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85200222021-10-18 Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines Ascher, Benjamin Rzany, Berthold Kestemont, Philippe Hilton, Said Heckmann, Marc Bodokh, Isaac Noah, Ernst Magnus Boineau, Dominique Kerscher, Martina Volteau, Magali Le Berre, Philippe Picaut, Philippe Aesthet Surg J Corrigendum Oxford University Press 2021-03-19 /pmc/articles/PMC8520022/ /pubmed/33739363 http://dx.doi.org/10.1093/asj/sjab111 Text en © 2021 The Aesthetic Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Corrigendum
Ascher, Benjamin
Rzany, Berthold
Kestemont, Philippe
Hilton, Said
Heckmann, Marc
Bodokh, Isaac
Noah, Ernst Magnus
Boineau, Dominique
Kerscher, Martina
Volteau, Magali
Le Berre, Philippe
Picaut, Philippe
Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title_full Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title_fullStr Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title_full_unstemmed Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title_short Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
title_sort corrigendum to: liquid formulation of abobotulinumtoxina: a 6-month, phase 3, double-blind, randomized, placebo-controlled study of a single treatment, ready-to-use toxin for moderate-to-severe glabellar lines
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520022/
https://www.ncbi.nlm.nih.gov/pubmed/33739363
http://dx.doi.org/10.1093/asj/sjab111
work_keys_str_mv AT ascherbenjamin corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT rzanyberthold corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT kestemontphilippe corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT hiltonsaid corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT heckmannmarc corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT bodokhisaac corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT noahernstmagnus corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT boineaudominique corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT kerschermartina corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT volteaumagali corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT leberrephilippe corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines
AT picautphilippe corrigendumtoliquidformulationofabobotulinumtoxinaa6monthphase3doubleblindrandomizedplacebocontrolledstudyofasingletreatmentreadytousetoxinformoderatetosevereglabellarlines

Ejemplares similares